Home Newsfeeds Baird Maintains Outperform on Frequency Therapeutics, Lowers Price Target to $4

Baird Maintains Outperform on Frequency Therapeutics, Lowers Price Target to $4

Baird analyst Jack Allen maintains Frequency Therapeutics (NASDAQ:FREQ) with a Outperform and lowers the price target from $10 to $4.

byBenzinga Newsdesk

February 14, 2023

1 minute read

Baird analyst Jack Allen maintains Frequency Therapeutics (NASDAQ:FREQ) with a Outperform and lowers the price target from $10 to $4.

Analyst Ratings

Analyst Expectations for Intra-Cellular Therapies’s Future

By Benzinga Insights

June 22, 1:00 PM

Over the past 3 months, 14 analysts have published their opinion on Intra-Cellular Therapies (NASDAQ:ITCI) stock. These analysts…

ITCI

Bellerophon Therapeutics Q2 EPS $(0.43) Down From $(0.36) YoY

By Benzinga Newsdesk

August 15, 8:36 AM

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.43) per share. This is a 19.44 percent decrease over losses of $(0.36) per share from the same period last year.

BLPH

Copart, Inc. Announces Senior Leadership Appointments; Hessel Verhage Appointed To Chief Operating Officer, Stephen Powers, Who Has Served As COO, Has Assumed The Role Of Chief Business Development Officer

By Benzinga Newsdesk

January 15, 7:31 PM

Copart, Inc. (NASDAQ:CPRT) is pleased to announce the appointment of three new members to its senior executive leadership team: Chief Marketing Officer (CMO) David (Dave) Kang, Chief Product Officer (CPO) Neel Madhvani,

CPRT

Northern Midland Basin Expansion Set To Boost SM Energy: Analyst Lifts EPS Estimates

By Nabaparna Bhattacharya

June 22, 2:04 PM

Susquehanna analyst Biju Perincheril reiterated a Neutral rating on the shares of SM Energy Company (NYSE: SM),

Baird Maintains Outperform on Frequency Therapeutics, Lowers Price Target to $4

Related Posts

Analyst Expectations for Intra-Cellular Therapies’s Future

Bellerophon Therapeutics Q2 EPS $(0.43) Down From $(0.36) YoY

Copart, Inc. Announces Senior Leadership Appointments; Hessel Verhage Appointed To Chief Operating Officer, Stephen Powers, Who Has Served As COO, Has Assumed The Role Of Chief Business Development Officer

Northern Midland Basin Expansion Set To Boost SM Energy: Analyst Lifts EPS Estimates